Effectiveness of medical treatment for bipolar disorder regarding suicide, self-harm and psychiatric hospital admission: between- and within-individual study on Danish national data

Background Mood stabilisers are the main treatment for bipolar disorder. However, it is uncertain which drugs have the best outcomes. Aims To investigate whether rates of suicide, self-harm and psychiatric hospital admission in individuals with bipolar disorder differ between mood stabilisers. Method A cohort design was applied to people aged ≥15 years who were diagnosed with bipolar disorder and living in Denmark during 1995–2016. Treatment with lithium, valproate, other mood stabilisers and antipsychotics were compared in between- and within-individual analyses, and adjusted for sociodemographic characteristics and previous self-harm. Results A total of 33 337 individuals with bipolar disorder were included (266 900 person-years). When compared with individuals not receiving treatment, those receiving lithium had a lower rate of suicide (hazard ratio 0.40, 95% CI 0.31–0.51). When comparing treatment and non-treatment periods in the same individuals, lower rates of self-harm were found for lithium (hazard ratio 0.74, 95% CI 0.61–0.91). Lower rates of psychiatric hospital admission were found for all drug categories compared with non-treatment periods in within-individual analyses (P<0.001). The low rates of self-harm and hospital admission for lithium in within-individual analyses were supported by results of between-individual analyses. Conclusions Lithium was associated with lower rates of suicide, self-harm and psychiatric hospital readmission in all analyses. With respect to suicide, lithium was superior to no treatment. Although confounding by indication cannot be excluded, lithium seems to have better outcomes in the treatment of bipolar disorder than other mood stabilisers.

[1]  J. Kehr,et al.  Cholinergic regulation of vascular endothelial function by human ChAT+ T cells , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Vieta,et al.  Overview of lithium's use: a nationwide survey , 2021, International Journal of Bipolar Disorders.

[3]  E. Vieta,et al.  Overview of Lithium´s Use: A Nationwide Survey , 2020 .

[4]  A. Nierenberg,et al.  20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings. , 2020, The American journal of psychiatry.

[5]  P. Zandi,et al.  Trends in prescriptions of lithium and other medications for patients with bipolar disorder in office-based practices in the United States: 1996-2015. , 2020, Journal of affective disorders.

[6]  C. Clements,et al.  Relative toxicity of mood stabilisers and antipsychotics: case fatality and fatal toxicity associated with self-poisoning , 2018, BMC Psychiatry.

[7]  A. Tanskanen,et al.  Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder , 2018, JAMA psychiatry.

[8]  Katharine A Smith,et al.  Lithium and suicide in mood disorders: Updated meta‐review of the scientific literature , 2017, Bipolar disorders.

[9]  A. Sjölander,et al.  Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder. , 2017, The American journal of psychiatry.

[10]  G. Goodwin,et al.  Pharmacological treatment and risk of psychiatric hospital admission in bipolar disorder. , 2017, The British journal of psychiatry : the journal of mental science.

[11]  M. Nordentoft,et al.  Incidence Rates of Deliberate Self-Harm in Denmark 1994–2011 , 2016, Crisis.

[12]  Louise Marston,et al.  Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study. , 2016, JAMA psychiatry.

[13]  P. Andersen,et al.  Nationwide and population‐based prescription patterns in bipolar disorder , 2016, Bipolar disorders.

[14]  I. Thiblin,et al.  Are suicide deaths under-reported? Nationwide re-evaluations of 1800 deaths in Scandinavia , 2015, BMJ Open.

[15]  A. Erlangsen,et al.  Danish nationwide registers for public health and health-related research , 2015, Scandinavian journal of public health.

[16]  Donald R. Miller,et al.  Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study , 2014, BMC Psychiatry.

[17]  M. Goldacre,et al.  Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage , 2014, Journal of the Royal Society of Medicine.

[18]  J. Sundquist,et al.  Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. , 2013, JAMA psychiatry.

[19]  K. Saunders,et al.  Clinical assessment and crisis intervention for the suicidal bipolar disorder patient , 2013, Bipolar disorders.

[20]  Andrea Cipriani,et al.  Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis , 2013, BMJ.

[21]  T. Laursen Life expectancy among persons with schizophrenia or bipolar affective disorder , 2011, Schizophrenia Research.

[22]  Guy M. Goodwin,et al.  The course of bipolar disorder , 2010 .

[23]  Y. Conwell,et al.  Increased use of antidepressants and decreasing suicide rates: a population-based study using Danish register data , 2008, Journal of Epidemiology & Community Health.

[24]  R. Kessler,et al.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. , 2007, Archives of general psychiatry.

[25]  A. Young,et al.  Lithium in maintenance therapy for bipolar disorder , 2006, Journal of psychopharmacology.

[26]  K. Jamison,et al.  Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. , 2004, The American journal of psychiatry.

[27]  L. Kessing,et al.  Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark , 2003, Acta psychiatrica Scandinavica. Supplementum.

[28]  S. Østergaard,et al.  Real-world effectiveness of mood stabilizers on self-harm and suicide attempts in patients with bipolar disorder: A 2-year mirror-image study , 2021 .

[29]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.